Literature DB >> 4311236

Plasma insulin: fluctuations in the "big" insulin component in man after glucose and other stimuli.

P Gorden, J Roth.   

Abstract

Plasma was filtered on G50 Sephadex, and two components of circulating insulin, "little" insulin and "big" insulin, were measured by immunoassay. The former component is indistinguishable from insulin, whereas the latter more closely resembles proinsulin and the other insulin-like substances isolated from the pancreas. In thin normal subjects, the fraction of plasma insulin that was big insulin (per cent "big"). 15-30 min after oral glucose, was less than 5%; per cent big rose 2- to 8-fold over the next hour and by 90-120 min represented 5-29% of the plasma insulin. In young thin subjects with idiopathic glucose intolerance associated with normal concentrations of plasma insulin, an identical pattern of big insulin was observed. In thin subjects in whom elevations of per cent big at 90-120 min during the standard test were only modest, starvation for 48 hr before the glucose administration resulted in a more pronounced rise in the per cent big insulin. Early after glucose administration to obese and acromegalic subjects, the per cent big was higher than in thin subjects. The magnitude of the elevation was roughly correlated with elevations in the fasting plasma insulin concentration. By 90-120 min, the per cent big in obese and acromegalic patients was the same range as in the thin subjects. Intravenously administered arginine and tolbutamide in a small number of subjects yielded a response that was similar to oral glucose; the per cent big was low early after stimulation and increased with time. In two patients with islet cell carcinomas, the per cent big was in the same range as in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4311236      PMCID: PMC297479          DOI: 10.1172/JCI106188

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  CRITICAL FACTORS IN EXCESSIVE SERUM-INSULIN RESPONSE TO GLUCOSE. OBESITY IN MATURITY-ONSET DIABETES AND GROWTH HORMONE IN ACROMEGALY.

Authors:  J H KARAM; G M GRODSKY; F C PAVLATOS; P H FORSHAM
Journal:  Lancet       Date:  1965-02-06       Impact factor: 79.321

2.  The augmented insulin tolerance test for detecting insulin resistance.

Authors:  R FRASER; G F JOPLIN; L H OPIE; D RABINOWITZ
Journal:  J Endocrinol       Date:  1962-12       Impact factor: 4.286

3.  Comparison of plasma insulin levels following administration of tolbutamide and glucose.

Authors:  R S YALOW; H BLACK; M VILLAZON; S A BERSON
Journal:  Diabetes       Date:  1960 Sep-Oct       Impact factor: 9.461

4.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

5.  Circulating insulins. "Big" and "little".

Authors:  P Gorden; J Roth
Journal:  Arch Intern Med       Date:  1969-03

6.  Effect of porcine proinsulin in vitro on adipose tissue and diaphragm of the normal rat.

Authors:  W N Shaw; R E Chance
Journal:  Diabetes       Date:  1968-12       Impact factor: 9.461

7.  Plasma insulin and growth hormone levels in obesity and diabetes.

Authors:  R S Yalow; S M Glick; J Roth; S A Berson
Journal:  Ann N Y Acad Sci       Date:  1965-10-08       Impact factor: 5.691

8.  Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects.

Authors:  M Perley; D M Kipnis
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

9.  Porcine proinsulin: characterization and amino acid sequence.

Authors:  R E Chance; R M Ellis; W W Bromer
Journal:  Science       Date:  1968-07-12       Impact factor: 47.728

10.  Insulin biosynthesis: evidence for a precursor.

Authors:  D F Steiner; D Cunningham; L Spigelman; B Aten
Journal:  Science       Date:  1967-08-11       Impact factor: 47.728

View more
  17 in total

1.  Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids.

Authors:  Ximena Lopez; Aaron Cypess; Raquel Manning; Sheila O'Shea; Rohit N Kulkarni; Allison B Goldfine
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

2.  The excretion of proinsulin and insulin in urine.

Authors:  L Constan; M Mako; D Juhn; A H Rubenstein
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

3.  Specific and direct radioimmunoassay for human proinsulin in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

4.  Insulin regulates carboxypeptidase E by modulating translation initiation scaffolding protein eIF4G1 in pancreatic β cells.

Authors:  Chong Wee Liew; Anke Assmann; Andrew T Templin; Jeffrey C Raum; Kathryn L Lipson; Sindhu Rajan; Guifen Qiang; Jiang Hu; Dan Kawamori; Iris Lindberg; Louis H Philipson; Nahum Sonenberg; Allison B Goldfine; Doris A Stoffers; Raghavendra G Mirmira; Fumihiko Urano; Rohit N Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

Review 5.  Progress report. Diagnosis of insulinoma.

Authors:  V Marks
Journal:  Gut       Date:  1971-10       Impact factor: 23.059

6.  Circulating proinsulin-like component in man: increased proportion in hypoinsulinemic states.

Authors:  P Gorden; C M Hendricks; J Roth
Journal:  Diabetologia       Date:  1974-10       Impact factor: 10.122

7.  The role of carbohydrate and oral agents in the treatment of diabetes mellitus.

Authors:  W D Odell
Journal:  Calif Med       Date:  1973-10

8.  Serum proinsulin in normal and gestational diabetic pregnancy.

Authors:  C Kühl
Journal:  Diabetologia       Date:  1976-08       Impact factor: 10.122

9.  Acute and steady-state insulin responses to glucose in nonobese diabetic subjects.

Authors:  R L Lerner; D Porte
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

10.  Circulating insulin: th proinsulin-like properties of "big" insulin in patients withou islet cell tumors.

Authors:  B M Sherman; P Gorden; J Roth; P Freychet
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.